Manas AI

Manas AI is an artificial-intelligence drug-discovery company co-founded by Reid Hoffman and physician-scientist Siddhartha Mukherjee, launched in late 2024 and backed by General Catalyst and Greylock. The company applies machine learning and computational biology to accelerate the discovery and design of new medicines, with an initial focus on hard-to-treat cancers such as breast and prostate cancer and lymphoma. Manas AI operates as a private biotech / therapeutics research organization rather than a developer-facing platform: as of this profile it publishes no public API, developer portal, SDKs, or technical documentation. This entry is maintained in the API Evangelist network as a company profile surfaced from the General Catalyst portfolio.

Manas AI is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Drug Discovery, Biotechnology, and Healthcare.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyArtificial IntelligenceDrug DiscoveryBiotechnologyHealthcareMachine LearningOncologyLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/manas-ai: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: manas-ai
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/manas-ai.png
name: Manas AI
description: 'Manas AI is an artificial-intelligence drug-discovery company co-founded by Reid Hoffman and physician-scientist
  Siddhartha Mukherjee, launched in late 2024 and backed by General Catalyst and Greylock. The company applies machine learning
  and computational biology to accelerate the discovery and design of new medicines, with an initial focus on hard-to-treat
  cancers such as breast and prostate cancer and lymphoma. Manas AI operates as a private biotech / therapeutics research
  organization rather than a developer-facing platform: as of this profile it publishes no public API, developer portal, SDKs,
  or technical documentation. This entry is maintained in the API Evangelist network as a company profile surfaced from the
  General Catalyst portfolio.'
url: https://raw.githubusercontent.com/api-evangelist/manas-ai/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Artificial Intelligence
- Drug Discovery
- Biotechnology
- Healthcare
- Machine Learning
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 0
  pass: local-v1